4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001721020-26-000002
Director sold 2,625 shares at $10.72 ($28,140)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Seth Alpna Director | 2026-06-04 | Sale 10b5-1 | −2,625 | $10.72 | $28,140 | 9,767 | D |
| Open-market sales · 2,625 sh · avg $10.72 · $28,140 | |||||||
Loading xslF345X06/form4-06052026_040607.xml…